(22 days)
No
The device description and lack of mention of AI/ML terms or data sets indicate it is a mechanical oral appliance.
Yes
The device is intended to reduce or alleviate night time snoring and mild to moderate obstructive sleep apnea (OSA), which are medical conditions, thereby providing a therapeutic benefit.
No
The device is described as an anti-snoring device intended to reduce or alleviate snoring and mild to moderate obstructive sleep apnea. Its function is to treat, not diagnose, these conditions as evidenced by its mechanical components designed to adjust the jaw position.
No
The device description explicitly lists physical components (lower tray, upper tray, impression material, hook mechanism), indicating it is a hardware device.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is to reduce or alleviate snoring and mild to moderate obstructive sleep apnea. This is a therapeutic purpose, not a diagnostic one.
- Device Description: The device is a physical appliance worn in the mouth. It does not involve the analysis of biological samples (like blood, urine, or tissue) which is characteristic of IVDs.
- Lack of IVD-related information: The description does not mention any processes or components related to in vitro testing, such as reagents, calibrators, controls, or analytical methods for biological samples.
IVDs are devices used to examine specimens derived from the human body to provide information for diagnostic, monitoring, or compatibility purposes. This device does not fit that description.
N/A
Intended Use / Indications for Use
The TAP T is intended to reduce or alleviate night time snoring and mild to moderate obstructive sleep apnea, OSA
Product codes
LRK
Device Description
The TAP T Anti -- snoring device is comprised of --
- 트 Lower tray fitted over the lower teeth.
- . Upper tray fitted over the upper teeth.
- 트 Impression material
- . Hook mechanism to attach to lower tray to upper tray
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Adult patients 18years and older
Intended User / Care Setting
Home and sleep laboratories
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Nellcor Puritan Bennett - TAP - K962516, Thornton Oral Applicance -TOA- K972061, TAP II - K060388
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 872.5570 Intraoral devices for snoring and intraoral devices for snoring and obstructive sleep apnea.
(a)
Identification. Intraoral devices for snoring and intraoral devices for snoring and obstructive sleep apnea are devices that are worn during sleep to reduce the incidence of snoring and to treat obstructive sleep apnea. The devices are designed to increase the patency of the airway and to decrease air turbulence and airway obstruction. The classification includes palatal lifting devices, tongue retaining devices, and mandibular repositioning devices.(b)
Classification. Class II (special controls). The special control for these devices is the FDA guidance document entitled “Class II Special Controls Guidance Document: Intraoral Devices for Snoring and/or Obstructive Sleep Apnea; Guidance for Industry and FDA.”
0
Airway Management Inc. 6116 North Central Expressway Suite 605 Dallas, Texas 75206
JUL 1 2 2006
Non-Confidential Summary of Safety and Effectiveness Page 1 of 3 May 25, 2006
Airway Management Inc.
6116 North Central Expressway
Suite 605
Dallas, Texas 75225
Tel - (214) 369-0978
Fax - (214) 691-4934
Official Contact: | Darren Henderson |
---|---|
Proprietary or Trade Name: | TAP T |
Common / Usual Name: | Dental Device - Anti Snoring / Obstructive Sleep Apnea Device |
Classification Name: | Anti-Snoring /Obstructive Sleep Apnea Device |
Device: | TAP T |
Predicate Devices: | Nellcor Puritan Bennett - TAP - K962516 Thornton Oral Applicance -TOA- K972061 TAP II - K060388 |
Device Description: ----------------------------------------------------------------------------------------------------------------------------------------------------------
The TAP T Anti -- snoring device is comprised of --
- 트 Lower tray fitted over the lower teeth.
- . Upper tray fitted over the upper teeth.
- 트 Impression material
- . Hook mechanism to attach to lower tray to upper tray
1
Intended Use: | |
---|---|
Indicated Use - - | The TAP T is intended to reduce or alleviate night time snoring |
and mild to moderate obstructive sleep apnea, OSA | |
Target population | Adult patients 18years and older |
Environment of Use - - | Home and sleep laboratories |
and the comments of the comments of the comments of the comments of
:
.
: 1000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
and the control control control control controllers and
2
Image /page/2/Picture/1 description: The image shows the seal of the Department of Health and Human Services (HHS) of the United States. The seal features the department's name encircling a symbol. The symbol is a stylized representation of a human figure, with three overlapping profiles facing to the right, suggesting a sense of community and support.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
JUL 1 2 2006
Mr. Darren Henderson Quality Manager Airway Management, Incorporated 6116 North Central Expressway Suite 605 Dallas. Texas 75206
Re: K061732
Trade/Device Name: TAP T Regulation Number: 872.5570 Regulation Name: Intraoral Device for Snoring and Intraoral Devices for Snoring and Obstructive Sleep Apnea Regulatory Class: II Product Code: LRK Dated: May 25, 2006 Received: June 20, 2006
Dear Mr. Henderson:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
3
Page 2 - Mr. Henderson
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours.
Quy Sulom for
Chiu Lin. PK D Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
61732
ATIONS FOR USE INST 510(k) Number: (To be assigned) TAP T Device Name:
Intended Use: To reduce or alleviate night time snoring and mild to moderate obstructive sleep apnea (OSA). Home and sleep laboratories Environment of use:
Single patient – multi – use Disposable / Reusable:
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription User
(Per CFR 801.109)
or
Over-the-counter use_
Susan Ryan
sign-On).
ion of Anesthesiology, General Hospital,
ion Control, Dental Devices
) Number: 1561232